AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06672198 — intervention group
Intervention type: PROCEDURE
Intervention: ERAC protocol
Description: our study aimed to evaluate pre-peri-post operative practices in women who underwent elective cesarean section (CS) according to the ERAC protocol. In this context, this study aimed to describe the implementation status of the recommendations regarding the ERAC protocol in CS operations, to identify the missing aspects of the ERAC protocol and to raise awareness about its benefits.
Study NCT06485232 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Universal BCMA CAR-T; Universal CD19 CAR-T
Description: Universal BCMA CAR-T; Universal CD19 CAR-T
Study NCT04149821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Umbralisib
Description: * Lead-in cycle of 28 days (Cycle -1) of umbralisib monotherapy, 800mg oral daily~* Continued 800mg oral daily dosing in all subsequent cycles (combination therapy cycles 1-6, then continued monotherapy cycle 7 and beyond)
Study NCT06619834 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Financial Navigation and Peer Support
Description: A combined intervention of technology-supported financial navigation and peer support: A professional financial navigator from TailorMed will use the software to assist participants in exploring options to reduce their specific economic barriers to treatment and care, and non-medical social risks. Participants will also be matched with a Peer Supporter to help improve the participants\&#39; diabetes self-management.
Study NCT06619834 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Financial Navigation Only
Description: A professional financial navigator from TailorMed will use the software to assist participants in exploring options to reduce their specific economic barriers to treatment and care, and non-medical social risks.
Study NCT05840497 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance exercise
Description: The intervention group will train 3 times per week (30 minutes with 15 min warm-up). The resistance exercise is described as the voluntary contraction of the skeletal muscle of a particular muscle group against some type of resistance, using light weights, elastic bands or the weight of the body itself.~Patients will be offered online sessions, they will receive a document with recommendations and a link to the videos with instructions.~.
Study NCT04149821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ublituximab
Description: -Co-administered on days 1 and 2 (dose split over days 1 and 2), 8, 15 of cycle 1 then on day 1 for subsequent cycles 2-6
Study NCT06696469 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Feasibility and reliability of using BeCureTM Virtual Reality in the evaluation of upper extremity motor functions in stroke patients
Description: The applicability and reliability of virtual reality systems are important factors to consider. Based on this, this study aimed to investigate the feasibility of using BeCureTM virtual reality in the evaluation of upper extremity functions after stroke.The feasibility of using BeCureTM virtual reality in stroke patients will be determined according to the System Usability Scale (SUS) score.The safety of the use of BeCureTM virtual reality in stroke patients will be assessed with a patient feedback questionnaire. The relationship between the use of BeCureTM virtual reality and cognitive functions in stroke patients will be determined by the Montreal Cognitive Assessment Scale and Mini Mental State Examination.It was aimed to examine the effects of demographic characteristics, accompanying cognitive disorders and upper extremity motor disorders that may affect the evaluation and response to treatment on virtual reality applications.
Study NCT06700629 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Distal Penile Hypospadias (Disorder)
Description: Three operations which are Tubularized incised plate urethroplasty (TIP), Mathieu and meatal advancement and glanuplasty (MAGPI).~A three experienced operators with number of operations done by each one more than one hundred operation in the last year.~The operators will be fixed for each surgical technique as follows:~1. Doctor (A) for Matheiu. ( 35 operations)~2. Doctor (M) for MAGPI. ( 35 operations)~3. Doctor (S) for TIP ( 35 operations). Tubularized incised plate urethroplasty:(3,6) Indication: for distal penile hypospadias with or without penile curvature with any width of the uretheral plate and also for any type of distal hypospadias associated with curvature.~Key steps for this operation are as follows:~Glans retraction using stay suture 4-0 or 5-0 silk. Uretheral catheter pass through hypospadic meatus to bladder. Parallel longitudenal incision is done 1-2mm proximal to hypospadic meatus. A circumferential incision is made 2-3 mm below coronal sulcus dorsally
Study NCT06698614 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MRI
Description: MRI imaging of the kidney and heart with an intravenous infusion of manganese dipyridoxl diphosphate (Mangafodipir, MnDPDP).
Study NCT06698614 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood tests
Description: full blood count, urea and electrolytes, liver function test, CRP, biomarkers for endothelial function, storage of serum and plasma for future analyses.
Study NCT06048744 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: external oblique intercostal block
Description: U S guided external oblique intercostal block after induction.
Study NCT06048744 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Erector Spine block
Description: US guided erector spine block after induction
Study NCT05888220 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: warm salt water bath
Description: Warm water and warm salt water bath were applied to the hands and feet of the patients. It is a non-pharmacological intervention
Study NCT04534530 — intervention group
Intervention type: OTHER
Intervention: Systematic screening for ischemic heart disease in type 2 diabetic patients
Description: Systematic screening for ischemic heart disease in type 2 diabetic patients at very high cardiovascular risk, without known coronary heart disease.
Study NCT04691362 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tranexamic Acid Oral Product
Description: Oral administration of 2 grammes tranexamic acid 2 hours before skin incision and 2 grammes oral tranexamic acid 4 hours after first administration
Study NCT04691362 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tranexamic acid injection
Description: Intravenous administration of 1 gramme tranexamic acid 30 minutes before skin incision and 1 gramme intravenous tranexamic acid 4 hours after first administration
Study NCT06303804 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational videos
Description: Participants will be delivered a link to complete demographic information and the initial assessment. Upon completing the (initial) pre-test knowledge assessment, participants will be sent links to the three educational videos staggered across 7 days. Educational videos will determine gaps in knowledge related to opioid use and overdose based on questionnaire responses. Upon the completion of the 7 days, participants will be sent a link to the (final) post-test knowledge assessment to complete.
Study NCT05277883 — intervention group
Intervention type: RADIATION
Intervention: CT scan
Description: CT of the lower limb
Study NCT02028897 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional embryo culture
Study NCT02028897 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enclosed embryo culture
Study NCT04578873 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QPX7831
Description: capsule
Study NCT06698614 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Urine tests
Description: Urine protein, Urine creatinine
Study NCT04578873 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: placebo comparator
Description: oral matched placebo capsule
Study NCT05531214 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multidisciplinary Care Coordination Team
Description: The intervention group will be patients whose primary care clinicians will be receiving guidance and recommendations from the multidisciplinary team consisting of cardiologists, nephrologists, and specialty pharmacists.
Study NCT05853094 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ileostomy
Description: Protective loop ileostomy after low anterior resection
Study NCT05853094 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transverse colostomy
Description: Protective loop transverse colostomy after low anterior resection
Study NCT05861115 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Chang Gung Ventricular Systolic Dysfunction Screening Software
Description: This software is suitable for 12-lead ECG signals of adults over 20 years old, and assists doctors in screening patients for left ventricular systolic dysfunction.
Study NCT03059173 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Myo-Inositol + Levomefolic acid
Description: Dietary supplement Gynositol® MTHF containing myo-inositol (4 g) and Levomefolic acid on glucosamine salts(0.736 mg) in a same bags Supplementation started on average one month before treatment with Clomiphene citrate and continued throughout cycles of Clomiphene citrate (maximum 9 cycles). Treatment will be delivered during ultrasound visit at D12 of each cycle.
Study NCT03059173 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clomiphene Citrate
Description: Clomiphene citrate 50 mg. taking D2 to D6 of each cycle (maximum 9 cycles). Treatment will be delivered during ultrasound visit at D12 of each cycle and the dose will be increased if necessary.
Study NCT03059173 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Clomiphene Citrate
Description: Clomiphene citrate 50 mg. taking D2 to D6 of each cycle (maximum 9 cycles). Treatment will be delivered during ultrasound visit at D12 of each cycle and the dose will be increased if necessary.
Study NCT06698614 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiovascular analysis
Description: 24 hour blood pressure, arterial stiffness
Study NCT06702202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mixture of local anesthetics
Description: Marcaine® (bupivacaine HCl) 0,5% and Xylocaine® (Lidocaine HCL) 2% = 2:1 Given in Femoropopliteal block group (Group F)
Study NCT06702202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.5% hyperbaric bupivacaine
Description: Given in Subarachnoid block group (Group S)
Study NCT06701266 — intervention group
Intervention type: DEVICE
Intervention: Point of Care Test
Description: PoCT as a chairside test, ELISA as a gold standard
Study NCT06700499 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK120 300mg Q2W (JAK inhibitor users need to double the initial dose)
Description: AK120 300mg Q2W SC until week 14(JAK inhibitor users need to receive a first dose of 600mg SC)
Study NCT06700564 — intervention group
Intervention type: OTHER
Intervention: PET scan of FDG
Description: The enrolled patients will undergo PET examination, and the radiation dose generated during the examination will not cause physiological damage to the patients
Study NCT03059173 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: a placebo containing only 0.736 mg of 5-MTHF, glucosamine salts
Study NCT04093934 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychosocial stimulation
Description: Children will receive fortnightly sessions of psychosocial stimulation and nutritional support for one year during the study period.
Study NCT06700408 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dachaihu Decoction combined Erzhiwan with variation
Description: Chinese medicine granules
Study NCT05015153 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation (PR)
Description: 20 sessions of PR in respiratory rehabilitation centre will be performed over a period of 3 months
Study NCT06700408 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo granules
Description: Placebo granules
Study NCT06421233 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: massage
Description: Endorphin massage will be given for 15 minutes every 2 hours.
Study NCT04964089 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KSI-301
Description: Intravitreal Injection
Study NCT04964089 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aflibercept
Description: Intravitreal Injection
Study NCT04964089 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sham Procedure
Description: The sham is a procedure that mimics an intravitreal injection. It involves pressing the blunt end of an empty syringe (without a needle) against the anesthetized eye. It will be administered to participants in both treatments arms at applicable visits to maintain masking.
Study NCT06703463 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-1167
Description: Administered via oral capsule per dosing regimen.
Study NCT06703463 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diltiazem
Description: Diltiazem hydrochloride administered at a dose of 240 mg QD via oral capsules.
Study NCT05689034 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azvudine
Description: Azvudine po. 5mg daily for 7 days
Study NCT05689034 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo po. 5 tablets daily for 7 days
Study NCT04925479 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Asciminib Pediatric formulation group
Description: Asciminib Pediatric formulation group: Mini-tablets will be supplied as size 0 capsules containing 1 mg mini-tablets, taken orally:~10 mg (10x 1 mg tablets in capsule) 15 mg (15x 1 mg tablets in capsule) 20 mg (20x 1 mg tablets in capsule) 30 mg (30x 1 mg tablets in capsule)
Study NCT04925479 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Asciminib Adult formulation group
Description: Asciminib Adult formulation group:~40 mg tablets BID, taken orally. 20 mg tablets BID, taken orally.
Study NCT05290272 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ViFIVE Digital Care Progrma
Description: ViFive DCP (Digital Care Program) is a highly structured, protocolized, and individually tailored intervention consisting of personalized exercise therapy modules. ViFive DCP is delivered by a physical therapy team consisting of DPTs and a personal coach. The DCP consists of ten modules and its advancement will be determined by each patient's progress after the treatment team's review every week.
Study NCT06172933 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Move with Meaning
Description: Participants will engage in twice weekly text message sessions, will listen to a weekly audio session, and will work towards a physical activity goal each week, for a total of eight weeks.
Study NCT05684497 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LBPSP in Pregnancy
Description: LBPSP is a 50-minute interactive presentation as face to face program according to Pender's Health Promotion Model Parameters.
Study NCT05926544 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard implementation webinar and online training
Description: The one-hour webinar (either live or pre-recorded) will include updated information about the COVID-19 virus, variant nomenclature, booster eligibility, mechanisms of action, and outcomes.~The 30-minute online training addresses how to communicate about COVID-19 vaccinations, presents a 5-step process for initiating conversations, includes example verbiage about how to address specific concerns, and has example videos that show how to implement the 5-step process with vaccine hesitant patients.
Study NCT05655182 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PIV5-vectored RSV Vaccine (BLB-201) Low Dose
Description: BLB201 10\^6 PFU
Study NCT05926544 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual facilitation
Description: This intervention involves a 30-minute virtual facilitation site visit and 8 30-minute virtual facilitator coaching sessions. The virtual site visit over Zoom will establish the personnel and workflows at each pharmacy and allow the facilitator to establish rapport. Weekly Zoom calls will allow the virtual facilitator to work with a participant to review overall implementation challenges associated with approaching patients, delivering the intervention, and documenting results. Lastly, either the facilitator or the participant can request and schedule a Zoom call to go over any pressing implementation issue in need of rapid attention (e.g., technical difficulties with the website).
Study NCT05655182 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PIV5-vectored RSV Vaccine (BLB-201) High Dose
Description: BLB201 10\^7 PFU
Study NCT05655182 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo used for the trial will be the same as the diluent (0.9% sterile saline) used for the low dose group (10\^6 PFU).
Study NCT05655182 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: The placebo used for the trial will be the same as the diluent (0.9% sterile saline) used for the low dose group (10\^6 PFU).
Study NCT04991311 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glepaglutide
Description: Glepaglutide will be delivered in a single-use autoinjector.
Study NCT06458712 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DSB2455
Description: PARP1 inhibitor
Study NCT06572280 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PNS group
Description: non-invasive phrenic nerve stimulation
Study NCT06574100 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cannabidiol
Description: Patients in the first arm cross-over will receive either a single bolus dose of 250mg buccally administered or 1000mg CBD powder and cross over to vice-versa after 21 days.
Study NCT06574100 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cannabidiol
Description: Patients will be randomised to receive 3000mg oral CBD fasting or Fed, they will the cross over to the other group 21 days following the first administration.
Study NCT05933226 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Khanya
Description: Khanya is a peer-delivered, behavioral intervention to improve HIV medication adherence and reduce problematic SUD symptoms. Participants will either receive Khanya Step 1 or if they continue to struggle with ART adherence, they will be stepped up to the more intensive intervention, Khanya Step 2.
Study NCT06500052 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BL-M17D1
Description: Administration by intravenous infusion for a cycle of 3 weeks.
Study NCT05871164 — intervention group
Intervention type: PROCEDURE
Intervention: Pancreatic radiofrequency
Description: Pancreatic radiofrequency is similar to a puncture under echoendoscopy. The lesion is located then punctured by transgastric or transduodenal route either using a 19 gauge needle with exchange of the stylet for a probe, or using a 19 gauge needle whose distal end of 5-10 mm corresponds to the active part, connected to a generator with an integrated cooling system.
Study NCT04642105 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sensor-Dot and Plug 'n Patch system
Description: We will use a small, unobtrusive wearable (Sensor-Dot) to measure different biosignals (EEG, ECG, EMG, motion, skin temperature, respiration and oxygen saturation) for up to one year using newly developed skin adhesives and patches (Plug 'n Patch system)
Study NCT05640934 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Melatonin
Description: The patients will be given 5 mg melatonin the night before surgery, 12 hours before the scheduled time of surgery, followed by another 5 mg melatonin two hours before surgery.
Study NCT05640934 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The patients will be premedicated with placebo tablets, which will be administered at the same times as the melatonin group.
Study NCT06208618 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education and Motivational Interviews
Description: The diabetes education aimed at supporting diabetes self-management in adolescents will include the following topics:~* What is Diabetes?~* Treatment in Diabetes~* Insulin Therapy~* Nutritional Therapy~* Physical Activity/Exercise~* Acute Complications of Diabetes~  * Hypoglycemia~ * Hyperglycemia~ * Diabetic Ketoacidosis~* Diabetes Management in Illness~Motivational interviews will consist of the following stages:~* First Meeting - Pre-awareness (Pre-contemplation)~* Second Meeting - Awareness (Contemplation)~* Third Meeting - Preparation~* Fourth Meeting - Taking Action (Action)~* Fifth Meeting - Maintenance~* Sixth Meeting - Termination or Review
Study NCT05344105 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Low frequency convex probe (ESAOTE Fixed Color Doppler Ultrasonography Device, Italy)
Description: A low frequency convex probe (ESAOTE Fixed Color Doppler Ultrasonography Device, Italy) device will be used while blocking in both groups.
Study NCT05888376 — intervention group
Intervention type: DEVICE
Intervention: Vascular access catheter to support dialysis or CRRT
Description: A specialised vascular access catheter to support bi-directional blood flow at high rates to allow extracorporeal removal of toxins by dialysis or CRRT
Study NCT06039332 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fitting of the audioprocessor with the auditory implant BCI602
Description: to compare the performance with BB system in two fitting-configurations (active comparator: DSL v5, experimental: DSL-BCD) using audiometric and subjective measures